Dr. Ojemuyiwa is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
100 Market Place Blvd
Ste 200
Cartersville, GA 30121Phone+1 770-386-7253Fax+1 770-382-6424
Education & Training
National Capital ConsortiumFellowship, Hematology and Medical Oncology, 2011 - 2014
Dwight David Eisenhower Army Medical CenterResidency, Internal Medicine, 2007 - 2010
Indiana University School of MedicineClass of 2007
Certifications & Licensure
GA State Medical License 2009 - 2026
WI State Medical License 2017 - 2019- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Study of Ramucirumab (LY3009806) Plus Docetaxel in Participants With Urothelial Cancer Start of enrollment: 2015 Jul 13
Publications & Presentations
PubMed
- 2 citationsComplete metabolic response of metastatic castration-resistant neuroendocrine carcinoma of the prostate after treatment with RRx-001 and reintroduced platinum doublets.Michelle A. Ojemuyiwa, Karen Zeman, Alexander I. Spira, Bryan Oronsky, Carolyn M. Ray
Clinical Case Reports. 2018-11-05 - Docetaxel extravasation: Pathologic correlation and treatment with intralesional steroidsJohn W Roman, Michelle A. Ojemuyiwa, Lisa M. Cordes, Ravi A. Madan, Leonard C. Sperling
JAAD Case Reports. 2017-07-01 - 2 citationsA Case of Poorly Differentiated Large-Cell Neuroendocrine Carcinoma of the Cecum: A Rare Malignancy, with Review of the Literature.Andrew Mertz, Michelle A. Ojemuyiwa
Case Reports in Oncology. 2016-09-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
